Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy-Reference-Cited by-同舟云学术

Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy

Published:2018-07 Issue:6 Volume:28 Page:1153-1161
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:International Journal of Gynecological Cancer

Author:

Bošnjak Snežana M.,Stamatovic Ljiljana,Borroni Maria Elisa,Rizzi Giada,Jordan Karin

Publisher

BMJ

Subject

Obstetrics and Gynecology,Oncology

Reference27 articles.

1. Novel Metals and Metal Complexes as Platforms for Cancer Therapy

2. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

4. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

5. 2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting;Drugs;2021-07

2. Low-dose olanzapine, sedation and chemotherapy-induced nausea and vomiting: a prospective randomized controlled study;Future Oncology;2021-06

3. Drugs in anesthesia: preventing postoperative nausea and vomiting;Current Opinion in Anaesthesiology;2021-05-10

Management of Chemotherapy-Induced Nausea and Vomiting (CINV): A Short Review on the Role of Netupitant-Palonosetron (NEPA)

;Core Evidence;2020-07

5. NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience;Journal of Oncology Pharmacy Practice;2020-06-06